Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Anthony H. V. Schapira »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anthony E. Lang < Anthony H. V. Schapira < Anthony Lang  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000199 (2010) Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000200 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000217 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Aged
3Antiparkinson Agents (administration & dosage)
3Benzothiazoles (administration & dosage)
3Double-Blind Method
3Female
3Humans
3Male
3Middle Aged
3Nervous system diseases
3Parkinson Disease (drug therapy)
3Parkinson disease
3Parkinson's disease
3Pramipexole
3Severity of Illness Index
2Antiparkinson Agents (adverse effects)
2Benzothiazoles (adverse effects)
2Delayed-Action Preparations (therapeutic use)
2Dopamine agonist
2Drug Administration Schedule
2Quality of Life
2Release
2dopamine agonist
1Adult
1Antiparkinson Agents (therapeutic use)
1Benzothiazoles (therapeutic use)
1Confidence Intervals
1Delayed-Action Preparations (administration & dosage)
1Delayed-Action Preparations (adverse effects)
1Dose-Response Relationship, Drug
1Drug Delivery Systems (methods)
1Evaluation
1Levodopa (therapeutic use)
1Pain Measurement
1Patient Satisfaction
1Safety
1Time Factors
1Treatment
1Treatment Outcome
1clinical trial
1delayed‐start
1neuroprotection
1pramipexole
1pramipexole extended release
1pramipexole‐extended release
1switch trial
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Anthony H. V. Schapira" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Anthony H. V. Schapira" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Anthony H. V. Schapira
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024